AI Algorithms in Prediction of ACS Based on Leukocyte Properties — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI Algorithms in Prediction of ACS Based on Leukocyte Properties — Stella

Home/Acute Coronary Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Acute Coronary Syndrome trials

Trial locations(1 site)

Austria

Landeskrankenhaus-Universitätsklinikum Graz, Graz, Styria / Steiermark

Key details

Sponsor

RobotDreams GmbH

Enrollment target

~2,700 participants

Started

February 2024

Primary completion

July 2026

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.